Chemotherapy benefits were observed more consistently across all T1c tumours, while, in women suffering from T1b tumours, benefits were reportedly observed mostly in relation to tumours with unfavourable characteristics, such as those associated with a grade 3, HER2-positive, and triple-negative status [28]. Here, ERBB2 is linked to neoplasm.